171 related articles for article (PubMed ID: 11238111)
1. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.
Lluís F; Roma J; Suelves M; Parra M; Aniorte G; Gallardo E; Illa I; Rodríguez L; Hughes SM; Carmeliet P; Roig M; Muñoz-Cánoves P
Blood; 2001 Mar; 97(6):1703-11. PubMed ID: 11238111
[TBL] [Abstract][Full Text] [Related]
2. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
[TBL] [Abstract][Full Text] [Related]
3. Urokinase-type plasminogen activator plays essential roles in macrophage chemotaxis and skeletal muscle regeneration.
Bryer SC; Fantuzzi G; Van Rooijen N; Koh TJ
J Immunol; 2008 Jan; 180(2):1179-88. PubMed ID: 18178858
[TBL] [Abstract][Full Text] [Related]
4. The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).
Suelves M; Vidal B; Ruiz V; Baeza-Raja B; Diaz-Ramos A; Cuartas I; Lluis F; Parra M; Jardi M; Lopez-Alemany R; Serrano AL; Munoz-Canoves P
Front Biosci; 2005 Sep; 10():2978-85. PubMed ID: 15970552
[TBL] [Abstract][Full Text] [Related]
5. Mice deficient in plasminogen activator inhibitor-1 have improved skeletal muscle regeneration.
Koh TJ; Bryer SC; Pucci AM; Sisson TH
Am J Physiol Cell Physiol; 2005 Jul; 289(1):C217-23. PubMed ID: 15716324
[TBL] [Abstract][Full Text] [Related]
6. Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.
Sisson TH; Nguyen MH; Yu B; Novak ML; Simon RH; Koh TJ
Blood; 2009 Dec; 114(24):5052-61. PubMed ID: 19812386
[TBL] [Abstract][Full Text] [Related]
7. Urokinase-type plasminogen activator supports liver repair independent of its cellular receptor.
Shanmukhappa K; Sabla GE; Degen JL; Bezerra JA
BMC Gastroenterol; 2006 Nov; 6():40. PubMed ID: 17134505
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of urokinase-type plasminogen activator (uPA) abrogates myogenesis in vitro.
Muñoz-Cánoves P; Miralles F; Baiget M; Félez J
Thromb Haemost; 1997 Mar; 77(3):526-34. PubMed ID: 9066006
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-specific expression of urokinase-type plasminogen activator promotes skeletal muscle regeneration.
Novak ML; Bryer SC; Cheng M; Nguyen MH; Conley KL; Cunningham AK; Xue B; Sisson TH; You JS; Hornberger TA; Koh TJ
J Immunol; 2011 Aug; 187(3):1448-57. PubMed ID: 21709151
[TBL] [Abstract][Full Text] [Related]
10. Alpha-enolase plasminogen receptor in myogenesis.
Lopez-Alemany R; Suelves M; Diaz-Ramos A; Vidal B; Munoz-Canoves P
Front Biosci; 2005 Jan; 10():30-6. PubMed ID: 15574344
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activation independent of uPA and tPA maintains wound healing in gene-deficient mice.
Lund LR; Green KA; Stoop AA; Ploug M; Almholt K; Lilla J; Nielsen BS; Christensen IJ; Craik CS; Werb Z; Danø K; Rømer J
EMBO J; 2006 Jun; 25(12):2686-97. PubMed ID: 16763560
[TBL] [Abstract][Full Text] [Related]
12. Plasmin generation dependent on alpha-enolase-type plasminogen receptor is required for myogenesis.
López-Alemany R; Suelves M; Muñoz-Cánoves P
Thromb Haemost; 2003 Oct; 90(4):724-33. PubMed ID: 14515195
[TBL] [Abstract][Full Text] [Related]
13. Urokinase-type plasminogen activator and macrophages are required for skeletal muscle hypertrophy in mice.
DiPasquale DM; Cheng M; Billich W; Huang SA; van Rooijen N; Hornberger TA; Koh TJ
Am J Physiol Cell Physiol; 2007 Oct; 293(4):C1278-85. PubMed ID: 17652428
[TBL] [Abstract][Full Text] [Related]
14. Neutralisation of uPA with a monoclonal antibody reduces plasmin formation and delays skin wound healing in tPA-deficient mice.
Jögi A; Rønø B; Lund IK; Nielsen BS; Ploug M; Høyer-Hansen G; Rømer J; Lund LR
PLoS One; 2010 Sep; 5(9):e12746. PubMed ID: 20856796
[TBL] [Abstract][Full Text] [Related]
15. Antibody-mediated targeting of the urokinase-type plasminogen activator proteolytic function neutralizes fibrinolysis in vivo.
Lund IK; Jögi A; Rønø B; Rasch MG; Lund LR; Almholt K; Gårdsvoll H; Behrendt N; Rømer J; Høyer-Hansen G
J Biol Chem; 2008 Nov; 283(47):32506-15. PubMed ID: 18799467
[TBL] [Abstract][Full Text] [Related]
16. Plasminogen-independent initiation of the pro-urokinase activation cascade in vivo. Activation of pro-urokinase by glandular kallikrein (mGK-6) in plasminogen-deficient mice.
List K; Jensen ON; Bugge TH; Lund LR; Ploug M; Danø K; Behrendt N
Biochemistry; 2000 Jan; 39(3):508-15. PubMed ID: 10642175
[TBL] [Abstract][Full Text] [Related]
17. Plasma tissue-type plasminogen activator increases fibrinolytic activity of exogenous urokinase-type plasminogen activator.
Shenkman B; Livnat T; Budnik I; Tamarin I; Einav Y; Martinowitz U
Blood Coagul Fibrinolysis; 2012 Dec; 23(8):729-33. PubMed ID: 22918041
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of cardiac fibrosis induced by urokinase plasminogen activator.
Stempien-Otero A; Plawman A; Meznarich J; Dyamenahalli T; Otsuka G; Dichek DA
J Biol Chem; 2006 Jun; 281(22):15345-51. PubMed ID: 16554301
[TBL] [Abstract][Full Text] [Related]
19. Tissue plasminogen activator-mediated fibrinolysis protects against axonal degeneration and demyelination after sciatic nerve injury.
Akassoglou K; Kombrinck KW; Degen JL; Strickland S
J Cell Biol; 2000 May; 149(5):1157-66. PubMed ID: 10831618
[TBL] [Abstract][Full Text] [Related]
20. Increased bone formation in mice lacking plasminogen activators.
Daci E; Everts V; Torrekens S; Van Herck E; Tigchelaar-Gutterr W; Bouillon R; Carmeliet G
J Bone Miner Res; 2003 Jul; 18(7):1167-76. PubMed ID: 12854826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]